Fernanda Boulos

Fernanda Boulos is an accomplished professional in the field of neuroscience and medical affairs, currently serving as Chief Scientific Officer at Instituto Butantan since April 2022. Prior to this role, Fernanda held various senior positions at Novartis from June 2013 to April 2022, including Executive Director for Evidence Generation and Gene Therapy in Latin America and Canada, as well as leading Neuroscience and Ophthalmology Clinical Development. Experience also includes serving as Medical Manager at Pfizer Pharmaceuticals from 2010 to 2013 and practicing as a neurologist at UNIFESP while pursuing a Ph.D. in neuroimmunology. Fernanda holds a medical degree from Pontifícia Universidade Católica de São Paulo and specialized training in neurology and neuroimmunology from UNIFESP.